Ruben Bill
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 4
-
- Angiogenesis and VEGF in Cancer 5
- Co-authors
- Gerhard Christofori (10 shared papers)Mikäel J. Pittet (5 shared papers)Marius Messemaker (2 shared papers)Allon M. Klein (2 shared papers)Ernesta Fagiani (5 shared papers)Genevieve M. Gerhard (1 shared paper)Robert Ivánek (3 shared papers)Stefanie Tiede (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Angiogenesis (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Oncogenesis (1 paper)
- Partner nations
- SwitzerlandUnited StatesNetherlands
In The Last Decade
Ruben Bill
20 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 333
- Oncology 554
- Immunology 374
- Immunology and Allergy 68
- Molecular Biology 557
Countries citing papers authored by Ruben Bill
This map shows the geographic impact of Ruben Bill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruben Bill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruben Bill more than expected).
Fields of papers citing papers by Ruben Bill
This network shows the impact of papers produced by Ruben Bill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruben Bill. The network helps show where Ruben Bill may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruben Bill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Distinct contributions of partial and full EMT to breast cancer malignancy Hit paper breakdown → | 2021 | 250 |
| 2 | A neutrophil response linked to tumor control in immunotherapy Hit paper breakdown → | 2023 | 229 |
| 3 | 2016 | 164 | |
| 4 | 2015 | 152 | |
| 5 | 2020 | 148 | |
| 6 | 2018 | 57 | |
| 7 | 2017 | 55 | |
| 8 | 2015 | 27 | |
| 9 | 2016 | 19 | |
| 10 | 2023 | 14 | |
| 11 | 2015 | 10 | |
| 12 | 2023 | 10 | |
| 13 | 2010 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2018 | 7 | |
| 17 | 2018 | 6 | |
| 18 | 2016 | 3 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Ruben Bill
Ruben Bill is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (4 papers), Cell Adhesion Molecules Research (3 papers), Immune Cell Function and Interaction (2 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (333 citations), Oncology (554 citations), Immunology (374 citations), Immunology and Allergy (68 citations) and Molecular Biology (557 citations). Ruben Bill has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Gerhard Christofori, Mikäel J. Pittet, Marius Messemaker, Allon M. Klein, Ernesta Fagiani, Genevieve M. Gerhard, Robert Ivánek, Stefanie Tiede, Laura Pisarsky and Jörg Hagmann. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Angiogenesis, Molecular Cancer Therapeutics, Clinical Cancer Research and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.